Advertorial
BUSINESS NEWS - Cancercare Outeniqua has welcomed new clinical and radiation oncologist and specialist in SBRT and SRS, Dr AW Dreyer, to the practice.
Dr Dreyer qualified as a clinical and radiation oncologist in 1992. He has a keen interest in prostate, brain, head and neck and sarcoma cancers and is a specialist in the field of stereotactic, IMRT and VMAT radiotherapy. He recently transferred from Cape Town and is now one of the resident oncologists at Cancercare Outeniqua.
What is stereotactic radiosurgery (SRS)?
Stereotactic radiosurgery (SRS) is a non-surgical radiation therapy used to treat functional abnormalities and small tumours of the brain.
It can deliver precisely targeted radiation in fewer high-dose treatments than traditional therapy, which can help preserve healthy tissue.
Stereotactic body radiotherapy (SBRT) gives radiotherapy from many different angles around the body with the beams meeting at the tumour.
This means the tumour receives a high dose of radiation and the surrounding tissue receives a much lower dose, lowering the risk of side effects.
Usually, a patient receives between one and eight treatments.
Stereotactic treatment for the body is called stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR).
'We bring you the latest Garden Route, Hessequa, Karoo news'
